ASLAN Pharmaceuticals Limited (ASLN) Misses Q4 EPS by 48c

ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) reported Q4 EPS of ($0.66), $0.48 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on ASLAN Pharmaceuticals Limited (ASLN) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c